Induce chromatin loop formation using the CLOuD9 Gene Expression Regulation System
Already included in SBI’s exclusive CLOuD9 Gene Expression Regulation Kit, CLOuD9 Inducer Reagent is also available separately from the kit. Learn more about the CLOuD9 Gene Expression Regulation Kit—introduced in a recent Nature Communications paper1—by visiting the product page.
CLOuD9 for Chromatin Loop Reorganization using CRISPR-dCas9:
References
Form chromatin loops with CLOuD9
Figure 1. The CLOuD9 System enables formation of inducible and reversible chromatin loops anywhere in the genome.
The CLOuD9 System consists of three components (Figure 1):
The use of the Cas9 null mutants enables accurate binding to a specific region of the genome via the user-designed guide RNA (gRNA) without generating any breaks in the DNA. Because the gRNA scaffolds from the two species bind more efficiently to their same-species Cas9 partner, we can direct the saCas9-ABI fusion localizes to one region of the DNA and the spCas9-PYL1 fusion to a second region of DNA.
The dimerization partners—ABI and PYL1—are part of the plant ABA signaling pathway, and form heterodimers in the presence of ABA. Dimerization of ABI and PYL1 is reversible, enabling formation of chromatin loops in the presence of ABA, and disassembly of the chromatin loops upon ABA washout.
Study the role of chromatin structure in gene expression
Figure 2. CLOuD9-induced chromatin loops increase gene expression in a context-dependent manner.1. A CLOuD9-induced chromatin loop at the β-globin locus leads to activation of gene expression in K562 cells but not in HEK293T cells, highlighting the importance of cellular context and the need for additional factors in gene expression. Inducer reagent (in DMSO) was added for either 24-hours or 72-hours. At the indicated time, cells in the “inducer only” treatment group were harvested and analyzed for gene expression, whereas cells in the “inducer + washout” treatment group were washed and then allowed to grow another 24- or 72-hours as indicated in the absence of inducer. Significance assessed relative to DMSO-treated control cells which were not transduced with the CLOuD9 System. * indicates P < 0.05, *** indicates P < 0.0001. 2. Unlike the β-globin locus, a CLOuD9-induced chromatin loop (treated with Inducer Reagent in DMSO) results in robust expression of the Oct4 gene in CLOud9/HEK293T cells compared to CLOuD9/HEK293T cells treated with DMSO only. The CLOuD9 System fusion proteins were targeted to the Oct4 promoter and the 5’ distal enhancer region upstream of the Oct4 promoter. *indicates P < 0.05.
System Biosciences,简称SBI,美国加州湾区新成立的生技公司,致力于独特、创新生物技术之开发,以研发利于基因及蛋白质功能鉴定、研究之崭新方法和工具为宗旨。 现阶段研发重心为RNA干扰(RNAi)研究之相关工具。 System Biosciences (SBI) 致力于开发独特、革新的技术,为客户研究蛋白组学和基因组学功能提供研究工具。SBI 是专业的慢病毒产品公司,提供基于慢病毒的所有相关产品、质粒、试剂盒及相关配套试剂和慢病毒延伸产品如IPS细胞多功能性诱导试剂盒和RNAi筛选文库。
SBI focuses on developing unique, innovative technologies that provide researchers with the tools to investigate and understand genomic and proteomic function. Our mission is to provide tools for the genome-wide analysis of the mechanisms that regulate cellular processes and biological responses.
Headquartered in Palo Alto about 30 miles south of San Francisco, SBI is geographically surrounded by highly successful research biotech companies (e.g., Affymetrix, Life Technologies, and Genentech) and some of the premier life science institutes in the world, including Stanford and the University of California, San Francisco.
As a small private biotechnology company, SBI capitalizes on a rich network of consultants and colleagues and continually collaborates to accelerate its development of innovative and novel applications. Currently, SBI has partnerships with over thirty scientists from several institutes.System Biosciences (SBI) consists of a highly motivated team committed to realizing the potential of its mission to develop and bring to market unique and innovative technology to investigate and understand genomic and proteomic function.
Possessing a diverse range of experience and knowledge, SBI's management and staff bring the skills, talent, and interest needed to support the company's continuing rapid growth.
A strong and proven background in creative research and product development with proficiency in genetic analysis, microarray technology, and cell biology
Extensive business development and management experience
A keen understanding of the needs of life scientists
Expertise in developing, marketing, and supporting consistent, high-quality research products
A clear focus on the need to build and maintain lasting customer relationships through support, service, and close customer interaction
View Products
View Products
View Products
View Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
miRNA & lncRNA Research Tools View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
CRISPR/Cas9 Systems View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
Imaging & Reporter Vectors View Products Imaging & Reporter VectorsView Products
Exosome Research View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
Cas9 & gRNA Delivery View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products
View Products Imaging & Reporter VectorsView Products